Product Images Atorvastatin Calcium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Atorvastatin Calcium NDC 70934-615 by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

label - 70934 615 30 Master Bottle Label Approval Rev A 04 20

label - 70934 615 30 Master Bottle Label Approval   Rev A 04 20

Arvastain Column Tatiets, USP 40 mg is a prescription drug with the NDC code 70934-615-30. It comes in the form of Calcium tablets and contains Atorvastatin USP 40 mg. Each bottle contains 30 tablets and is only available with a prescription. The manufacturer may be BRI based on the text provided.*

atorvastatin-fig-1 - atorvastatin fig 1

atorvastatin-fig-1 - atorvastatin fig 1

There is a graph representing the cumulative incidence of Atorvastatin and Placebo over 35 years, with a decrease in incidence for Atorvastatin when compared to Placebo. The graph also shows that Atorvastatin has a hazard ratio of 0.64 (p=0.0005).*

atorvastatin-fig-2 - atorvastatin fig 2

atorvastatin-fig-2 - atorvastatin fig 2

This text displays a chart or graph showing the cumulative hazard percentage over a 4-year follow-up period for a placebo group and a group treated with Atorvastatin. The graph indicates that Atorvastatin is associated with a lower risk of experiencing the primary endpoint compared to the placebo group.*

atorvastatin-fig-3 - atorvastatin fig 3

atorvastatin-fig-3 - atorvastatin fig 3

This text provides data on the percentage of subjects experiencing an event after taking different doses of atorvastatin for a certain period of time. The data shows that at a dose of 10 mg, no one experienced an event, while at a dose of 80 mg, the event rate was lowered by 22% compared to a placebo (P=0.0002). The chart shows the time to the first major cardiovascular endpoint in years.*

atorvastatin-st - atorvastatin st

atorvastatin-st - atorvastatin st

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.